These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28810651)

  • 1. Kanglaite inhibits the expression of drug resistance genes through suppressing PVT1 in cisplatin-resistant gastric cancer cells.
    Zhang XW; Liu L; Zhang XZ; Bo P
    Exp Ther Med; 2017 Aug; 14(2):1789-1794. PubMed ID: 28810651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer.
    Xu YD; Shang J; Li M; Zhang YY
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2794-2802. PubMed ID: 31002130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells.
    Zhan D; Ni T; Wang H; Lv M; Sunagawa M; Liu Y
    Anticancer Agents Med Chem; 2022; 22(2):270-279. PubMed ID: 34053427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
    Li M; Zhang YY; Shang J; Xu YD
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells.
    Zhang X; Bo P; Liu L; Zhang X; Li J
    Biomed Pharmacother; 2017 Aug; 92():580-585. PubMed ID: 28578256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
    Lan WG; Xu DH; Xu C; Ding CL; Ning FL; Zhou YL; Ma LB; Liu CM; Han X
    Oncol Rep; 2016 Jul; 36(1):263-70. PubMed ID: 27121324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression.
    Hang Q; Sun R; Jiang C; Li Y
    Anticancer Drugs; 2015 Jul; 26(6):632-40. PubMed ID: 25763542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reversion of multidrug resistance of human gastric cancer SGC7901/DDP cells by E2F-1 gene silencing].
    Lian C; Yang J; Wang X; Xie Y; Xiao Q
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):171-6. PubMed ID: 24785275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways.
    Liu E; Liu Z; Zhou Y; Mi R; Wang D
    Int J Clin Exp Med; 2015; 8(11):20565-72. PubMed ID: 26884974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
    BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a cisplatin-induced multidrug resistance cell line SK-Hep1/DDP.
    Zhou Y; Ling XL
    Chin J Cancer; 2010 Feb; 29(2):167-71. PubMed ID: 20109345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CDX2 in gastric cancer cells promotes the development of multidrug resistance.
    Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
    Am J Cancer Res; 2015; 5(1):321-32. PubMed ID: 25628941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway.
    Zhang ZD; Li Y; Fan Q; Zhao B; Tan B; Zhao XF
    Neoplasma; 2014; 61(6):627-37. PubMed ID: 25150310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect and mechanism of Yi-qi-hua-yu-jie-du decoction on the drug resistance of gastric cancer stem cells based on ABC transporters.
    Huang W; Wen F; Gu P; Liu J; Xia Y; Li Y; Zhou J; Song S; Ruan S; Gu S; Chen X; Shu P
    Chin Med; 2022 Aug; 17(1):93. PubMed ID: 35941687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway.
    Yang C; Hou A; Yu C; Dai L; Wang W; Zhang K; Shao H; Ma J; Xu W
    Onco Targets Ther; 2018; 11():983-996. PubMed ID: 29520149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
    Wang TH; Wan JY; Gong X; Li HZ; Cheng Y
    Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway.
    Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oridonin induces apoptosis and reverses drug resistance in cisplatin resistant human gastric cancer cells.
    He Z; Xiao X; Li S; Guo Y; Huang Q; Shi X; Wang X; Liu Y
    Oncol Lett; 2017 Aug; 14(2):2499-2504. PubMed ID: 28781688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.